Business Description
B&K Corp Ltd
SIC : 2836
ISIN : CNE100007CT6
Share Class Description:
HKSE:02396: Ordinary Shares- Class HTotal Employee Number:
100Compare
Compare
Traded in other countries / regions
02396.Hong Kong IPO Date
2025-12-22Description
B&K Corp Ltd is a China-based biopharmaceutical company committed to developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities. The company prominently focuses on the discovery, development and commercialization of therapies for wound healing, currently PDGF drugs. Its pipeline consisted of ten candidates, seven of which are PDGF candidates, including two Core Products, namely Pro-101-1 for the treatment of thermal burns and Pro-101-2 for the treatment of DFUs, which are rhPDGF-BB drugs. The company operates in a single reportable segment: the research and development of biopharmaceutical products. Geographically, the company generates all its revenue from Chinese Mainland.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 183.22 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.05 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 3.93 | |||||
Beneish M-Score | -1.48 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.36 | |||||
9-Day RSI | 41.75 | |||||
14-Day RSI | 43.4 | |||||
3-1 Month Momentum % | 7.44 | |||||
6-1 Month Momentum % | -39.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 17.11 | |||||
Quick Ratio | 17.11 | |||||
Cash Ratio | 17.01 | |||||
Days Sales Outstanding | 412.44 | |||||
Days Payable | 77604.16 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 92.03 | |||||
Operating Margin % | -15187 | |||||
Net Margin % | -14266.9 | |||||
EBITDA Margin % | -13768.28 | |||||
FCF Margin % | -15898.55 | |||||
OCF Margin % | -15287.71 | |||||
ROE % | -30.89 | |||||
ROA % | -25.89 | |||||
ROIC % | -135.12 | |||||
ROC (Joel Greenblatt) % | -476.53 | |||||
ROCE % | -28.09 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 804 | |||||
PB Ratio | 0.69 | |||||
Price-to-Tangible-Book | 0.72 | |||||
EV-to-EBIT | 3.22 | |||||
EV-to-EBITDA | 3.32 | |||||
EV-to-Revenue | -457.24 | |||||
EV-to-FCF | 2.88 | |||||
| Price-to-Net-Current-Asset-Value | 0.74 | |||||
| Price-to-Net-Cash | 0.75 | |||||
Earnings Yield (Greenblatt) % | 31.06 | |||||
FCF Yield % | -19.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
B&K Corp Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 0.573 | ||
| EPS (TTM) (HK$) | -0.695 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 43.4 | ||
| 14-Day ATR (HK$) | 0.434501 | ||
| 20-Day SMA (HK$) | 4.5415 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (HK$) | 3.5 - 37.2 | ||
| Shares Outstanding (Mil) | 117.66 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
B&K Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
B&K Corp Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
B&K Corp Ltd Frequently Asked Questions
What is B&K Corp Ltd(HKSE:02396)'s stock price today?
The current price of HKSE:02396 is HK$4.02. The 52 week high of HKSE:02396 is HK$37.20 and 52 week low is HK$3.50.
When is next earnings date of B&K Corp Ltd(HKSE:02396)?
The next earnings date of B&K Corp Ltd(HKSE:02396) is .
Does B&K Corp Ltd(HKSE:02396) pay dividends? If so, how much?
B&K Corp Ltd(HKSE:02396) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers